🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

307,02 USD

Máx. histórico

322,75

3 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-4,87%

Rango 52 semanas

175,89 – 326,63

Variación hoy

-4,87%

Cierre anterior

322,75

Rango de hoy

306,17 – 324,95

Volumen hoy

265.433

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
32,35 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 1 día
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/10/1993 45,85 45,85 43,04 43,04 +0,00% 6,12% 1.149
25/10/1993 43,04 43,51 43,04 43,04 +0,00% 1,09% 6.759
22/10/1993 45,85 45,85 43,04 43,04 -4,17% 6,12% 588
21/10/1993 43,04 44,92 43,04 44,92 +2,13% 4,35% 882
20/10/1993 45,85 45,85 43,51 43,98 +2,17% 5,10% 2.217
19/10/1993 42,11 45,85 42,11 43,04 +2,22% 8,89% 1.336
18/10/1993 43,98 45,85 42,11 42,11 -6,25% 8,51% 160
15/10/1993 43,98 45,85 42,58 44,92 -2,04% 7,45% 8.442
14/10/1993 43,04 45,85 41,17 45,85 +6,52% 10,87% 7.748
13/10/1993 40,24 43,04 40,24 43,04 +5,75% 6,98% 3.607
12/10/1993 37,43 41,17 37,43 40,70 +3,57% 10,00% 5.290
11/10/1993 37,43 40,24 37,43 39,30 +5,00% 7,50% 6.038
08/10/1993 37,43 37,43 37,43 37,43 -1,23% 0,00% 908
07/10/1993 37,43 39,30 37,43 37,90 +1,25% 5,00% 1.069
06/10/1993 37,43 37,43 37,43 37,43 +2,56% 0,00% 534
05/10/1993 36,49 36,49 36,49 36,49 +0,00% 0,00% 160
04/10/1993 38,37 39,30 35,56 36,49 +0,00% 9,76% 802
01/10/1993 35,56 38,37 35,56 36,49 -4,88% 7,89% 9.591
30/09/1993 35,56 38,37 35,56 38,37 +7,89% 7,89% 7.401
29/09/1993 38,37 38,37 35,56 35,56 +0,00% 7,32% 2.405
28/09/1993 38,37 38,37 35,56 35,56 -7,32% 7,32% 2.752
27/09/1993 35,56 38,37 35,56 38,37 +7,89% 7,89% 294
24/09/1993 38,37 38,37 35,56 35,56 -2,56% 7,32% 134
23/09/1993 36,49 36,49 36,49 36,49 +0,00% 0,00% 0
22/09/1993 35,56 36,49 35,56 36,49 +0,00% 2,63% 294
21/09/1993 38,37 38,37 36,03 36,49 -1,27% 6,10% 855
20/09/1993 37,43 37,43 35,56 36,96 -3,66% 5,00% 2.271
17/09/1993 35,56 38,37 35,56 38,37 +5,13% 7,89% 294
16/09/1993 36,49 36,49 36,49 36,49 +0,00% 0,00% 53
15/09/1993 39,30 39,30 35,56 36,49 -7,14% 9,52% 481